Jerry S. Lanchbury, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 120,000 shares at $40.12 ($4.8M) on 2018-06-18, disclosed to the SEC on 2018-06-19.
Open-market sale of $4.8M MYGN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.12 | 2,346 | $94K | 2.0% |
| 2 | $40.12 | 2,346 | $94K | 2.0% |
| 3 | $40.12 | 57,654 | $2.3M | 48.0% |
| 4 | $40.12 | 57,654 | $2.3M | 48.0% |
| Total | $40.12 avg | 120,000 | $4.8M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-06 | $2.0M | — | Filing → |
| MYGN | SELL | 2021-08-05 | $4.5M | — | Filing → |
| MYGN | SELL | 2021-07-14 | $4.9M | — | Filing → |